These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31032876)

  • 1. Fully bioresorption of an Absorb bioresorbable vascular scaffold after scaffold restenosis.
    Goncalves-Ramírez LR; Gutiérrez H; Rojas P; Cortés C; Serrador A; Ramos B; Toro J; Amat-Santos IJ; San Román JA
    Cardiol J; 2019; 26(2):209-211. PubMed ID: 31032876
    [No Abstract]   [Full Text] [Related]  

  • 2. First reported use of drug-coated balloon for bioresorbable in-scaffold restenosis.
    Latini RA; Buccheri D; Cortese B
    Catheter Cardiovasc Interv; 2017 Mar; 89(4):676-678. PubMed ID: 27649683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restenosis of Coronary Bioresorbable Vascular Scaffolds.
    Alfonso F; García-Guimaraes M
    Rev Esp Cardiol (Engl Ed); 2017 Jul; 70(7):527-531. PubMed ID: 28285939
    [No Abstract]   [Full Text] [Related]  

  • 4. Late Malapposition After Bare-Metal Stent, But Not Bioresorbable Scaffold: Insights on Intraindividual Heterogeneity in Plaque and Device Response.
    Cortese B; Buccheri D; Silva Orrego P; Biondi-Zoccai G
    J Invasive Cardiol; 2015 Aug; 27(8):E171-2. PubMed ID: 26232021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Full scaffold jacket for spontaneous coronary artery dissection of left anterior descending artery with magnesium reabsorbable scaffolds: 1 year follow-up.
    Bayon J; Santás-Álvarez M; Abellas-Sequeiros RA; Ocaranza-Sánchez R; González-Juanatey C
    Coron Artery Dis; 2020 Aug; 31(5):481-484. PubMed ID: 31860557
    [No Abstract]   [Full Text] [Related]  

  • 6. First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study.
    Ormiston JA; Serruys PW; Onuma Y; van Geuns RJ; de Bruyne B; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Hebert KM; Rapoza R; Garcia-Garcia HM
    Circ Cardiovasc Interv; 2012 Oct; 5(5):620-32. PubMed ID: 23048057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late-acquired scaffold malapposition and discontinuity that may be attributable to pathological coronary ectasia: Insights from optical coherence tomography.
    Miyazaki T; Ruparelia N; Kawamoto H; Sato K; Latib A; Colombo A
    Int J Cardiol; 2015; 186():136-8. PubMed ID: 25818756
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term intravascular follow-up of coronary bifurcation treatment with Absorb bioresorbable vascular scaffold.
    Vanhaverbeke M; McCutcheon K; Dubois C; Bennett J
    Acta Cardiol; 2018 Aug; 73(4):413-414. PubMed ID: 29277145
    [No Abstract]   [Full Text] [Related]  

  • 9. The Absorb Limits.
    Gómez Menchero AE; Camacho Freire SJ; Díaz Fernández JF; Roa Garrido J; León Jiménez J; Cardenal Piris R
    J Invasive Cardiol; 2016 Oct; 28(10):E122-E123. PubMed ID: 27705895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neointimal proliferation is associated with clinical restenosis 2 years after fully bioresorbable vascular scaffold implantation.
    Indolfi C; Mongiardo A; Spaccarotella C; Caiazzo G; Torella D; De Rosa S
    Circ Cardiovasc Imaging; 2014 Jul; 7(4):755-7. PubMed ID: 25027457
    [No Abstract]   [Full Text] [Related]  

  • 11. Randomized Comparison of Absorb Bioresorbable Vascular Scaffold and Mirage Microfiber Sirolimus-Eluting Scaffold Using Multimodality Imaging.
    Tenekecioglu E; Serruys PW; Onuma Y; Costa R; Chamié D; Sotomi Y; Yu TB; Abizaid A; Liew HB; Santoso T
    JACC Cardiovasc Interv; 2017 Jun; 10(11):1115-1130. PubMed ID: 28527768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined in vivo insights unraveling the underlying substrate of an acute myocardial infarction treated with a bioabsorbable vascular scaffold: from imaging to pathology.
    Alfonso F; Cuevas C; Jimenez-Quevedo P; Gonzalo N; Escribano N
    JACC Cardiovasc Interv; 2014 Mar; 7(3):e17-8. PubMed ID: 24650414
    [No Abstract]   [Full Text] [Related]  

  • 13. Very Late Restenosis Following Bioresorbable Scaffold Implantation.
    Okuno T; Yahagi K; Horiuchi Y; Aoki J; Simonton CA; Rapoza R; Saito S; Kimura T; Tanabe K
    JACC Cardiovasc Interv; 2017 Sep; 10(18):e167-e169. PubMed ID: 28866033
    [No Abstract]   [Full Text] [Related]  

  • 14. Optical coherence tomography assessment of late intra-scaffold dissection: a new challenge of bioresorbable scaffolds.
    Ohno Y; Mangiameli A; Attizzani GF; Capodanno D; Tamburino C
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):e11-2. PubMed ID: 25499307
    [No Abstract]   [Full Text] [Related]  

  • 15. Early Collapse of a Magnesium Bioresorbable Scaffold.
    Cubero-Gallego H; Vandeloo B; Gomez-Lara J; Romaguera R; Roura G; Gomez-Hospital JA; Cequier A
    JACC Cardiovasc Interv; 2017 Sep; 10(18):e171-e172. PubMed ID: 28935085
    [No Abstract]   [Full Text] [Related]  

  • 16. Rotational Atherectomy Combined With Bioresorbable Vascular Scaffold Implantation: A Feasible Approach for Recurrent In-stent Restenosis When Other Therapies Failed.
    Pereira-da-Silva T; Patrício L; Cruz Ferreira R
    J Invasive Cardiol; 2015 Jul; 27(7):E143-5. PubMed ID: 26136289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial optical coherence tomography of drug-eluting stent in-stent restenosis treated with the Absorb bioresorbable scaffold: an effective treatment?
    Farooq V; Mamas MA; Fraser DG; El-Omar M; Clarke B; Fath-Ordoubadi F
    EuroIntervention; 2015 Mar; 10(11):e1. PubMed ID: 25798636
    [No Abstract]   [Full Text] [Related]  

  • 18. Malabsorption of a Bioresorbable Vascular Scaffold System Leading to Very Late In-Scaffold Restenosis More Than 3.5 Years After Implantation: Assessment by Optical Coherence Tomography.
    Dommasch M; Langwieser N; Laugwitz KL; Ibrahim T
    JACC Cardiovasc Interv; 2016 Dec; 9(24):2571-2572. PubMed ID: 27889344
    [No Abstract]   [Full Text] [Related]  

  • 19. Early (before 6 months), late (6-12 months) and very late (after 12 months) angiographic scaffold restenosis in the ABSORB Cohort B trial.
    Nakatani S; Onuma Y; Ishibashi Y; Muramatsu T; Iqbal J; Zhang YJ; van Geuns RJ; Ormiston JA; Serruys PW
    EuroIntervention; 2015 Mar; 10(11):1288-98. PubMed ID: 24572936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optical coherence tomography evaluation of overlapping everolimus-eluting bioresorbable vascular scaffold implantation guided by enhanced stent visualization system.
    Biscaglia S; Secco GG; Tumscitz C; Di Mario C; Campo G
    Int J Cardiol; 2015 Mar; 182():1-3. PubMed ID: 25590956
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.